
In this video interview, Shaalan Beg, MD, MBA, FASCO, chief medical officer at ConcertAI, explains how AI can unlock unstructured chart data and cut coordinator screening time from hours to minutes, easing a clinical research workforce under strain.
A newly completed analysis from the Tufts Center for the Study of Drug Development shows that from 1980 through 2018, the FDA approved a total of 126 cancer drugs to treat solid and hematologic tumors. A dramatic increase to 27% from the 4% share of the 1980s.
For more findings, click






